个人简介
教育及工作经历
2003.09-2007.07 长江大学，生物工程，理学学士
2007.09-2010.07 三峡大学，免疫学，医学硕士
2010.09-2014.06 上海交通大学，生物学，理学博士

2016.04- present Johns Hopkins University School of Medicine, 神经生物学，博士后
(Ted Dawson’s Lab)

任职经历
2014.07-2016.07 三峡大学，讲师
2016.07-present 三峡大学，副教授

发表论文
Original Research
1. Wang H,Zhong CY, Wu JF, Huang YB, Liu CB. Enhancement of TAT cell membrane penetration efficiency by DMSO. J control Release. 2010; 143(1):64-70.
2. Xiong J^#, Wang H^#, Guo G, Wang S, He L, Chen H, Wu J. Male germ cell apoptosis and epigenetic histone modification induced by Tripterygium wilfordii Hook F. PLoS One. 2011; 6(6):e20751. (#co-first author).
3. Wang H, Shi LJ, Xiang J, Ding XB, Luo HC, Wang SZ, Wu J. Isolation, culture and transplantation of female germline stem cells from neonatal and prepubertal mice. Protoc Exch. 2013; doi:10.1038/protex.2013.004.
4. Wang H, Jiang M, Bi H, Chen X, He L, Li X, Wu J. Conversion of female germline stem cells from neonatal and prepubertal mice into pluripotent stem cells. J Mol Cell Biol. 2014; 6(2):164-71.
5. Xie W, Wang H, Wu J. Similar morphological and molecular signatures shared by female and male germline stem cells. Sci Rep. 2014; 4:5580.
6. Ma JL^#, Wang H^#, Wang YL, Luo YH, Liu CB. Enhanced peptide delivery into cells by using the synergistic effects of a cell-penetrating peptide and a chemical drug to alter cell permeability. Mol Pharm. 2015; 12(6):2040-2048. (#co-first author)
7. Wang H*, Ma J, Yang Y, Zeng F, Liu C. Highly efficient delivery of functional cargoes by a novel cell-penetrating peptide derived from SP140-like protein. Bioconjug Chem. 2016; 27(5): 1373-1381. (*Corresponding author)
8. Wang H*, Ma JL, Yang YG, Song Y, Wu J, Qin YY, Zhao XL, Wang J, Zou LL, Wu JF, Li JM, Liu CB. Efficient therapeutic delivery by a novel cell-permeant peptide derived from KDM4A protein for antitumor and antifibrosis. Oncotarget. 2016; 7(31): 49075-49090. (*Corresponding author)
9. Wang H*, Zhang M, Zeng F, Liu C. Hyperosmotic treatment synergistically boost efficiency of cell-permeable peptides. Oncotarget. 2016; 7(46): 74648-74657. (*Corresponding author)
10. Zeng XY, Zhang YQ, He XM, Wan LY, Wang H, Ni YR, Wang J, Wu JF, Liu CB. Suppression of hepatic stellate cell activation through downregulation of gremlin1 expression by the miR-23b/27b cluster. Oncotarget. 2016; 7(52): 86198-86210.
11. Luo C, Liu H, Wang H*, Wang J. Toll-Like Receptor 4 Signaling in High Mobility Group Box-1 Protein 1 Mediated the Suppression of Regulatory T-Cells. Med Sci Monit. 2017; 23:300-308. (*co-Corresponding author)
12. Zhou N, Wu J, Qin YY, Zhao XL, Ding Y, Sun LS, He T, Huang XW, Liu CB, Wang H*. Novel peptide MT23 for potent penetrating and selective targeting in mouse Melanoma cancer cells. Eur J Pharm Biopharm. 2017; 120:80-88. (*Corresponding author)
13. Hou L, Wang J, Li XY, Wang H, Liu GS, Xu B, Mei XX, Hua XG, Wu J. Characteristics of female germline stem cells from porcine ovaries at sexual maturity. Cell Transplant. 2018; 2-8.
14. Zhang M, Zhao XL, Geng JP, Liu HT, Zeng FH, Qin YY, Li J, Liu CB, Wang H*. Efficient penetration of Scp01-b and its DNA transfer abilities into cells. J Cell Physiol. 2019; 234(5):6539-6547. (*Corresponding author)
15. Ding Y, Zhao XL, Geng JP, Guo XL, Ma JL, Wang H*, Liu CB. Intracellular Delivery of Nucleic Acid by Cell Permeable hPP10 Peptide. J Cell Physiol. 2019; 234(7):11670-11678. (*Corresponding author)

Review Articles
16. Guo JJ, Wang H, Hu X. Reprogramming and Transdifferentiation Shift the Landscape of Regenerative Medicine. DNA Cell Biol. 2013; 32(10):565-572.
17. Deng XY, Wang H, Wang T, Fang XT, Zou LL, Li ZY, Liu CB. Non-Viral Methods For Generating Integration-Free, Induced Pluripotent Stem Cells. Curr Stem Cell Res Ther. 2015; 10(2):153-158.
18. Zeng FH, Huang FJ, Guo JJ, Hu XC, Liu CB, Wang H*. Emerging Methods to Generate Artificial Germ Cells from Stem Cells. Biol Reprod. 2015; 92(4):89,1-9. (*Corresponding author)
19. Liu H, Zeng F, Zhang M, Huang F, Wang J, Guo J, Liu C, Wang H*. Emerging landscape of cell penetrating peptide in reprogramming and gene editing. J Control Release. 2016; 226:124-37. (*Corresponding author)
20. Liu HT, Wang XQ, Yang R, Zeng WB, Peng D, Li, JS, Wang H*. Recent Development of Nuclear Molecular Imaging in Thyroid Cancer. Biomed Res Int. 2018; 2018: **. (*Corresponding author)
21. Wu J, Li J, Wang H*, Liu CB. Mitochondrial-targeted penetrating peptide delivery for cancer therapy. Expert Opin Drug Deliv. 2018; 15(10):951-964.(*Corresponding author)

Book Chapters
22. Wu J, Luo HC, Wang H. Germline stem cells. Curr Top Dev Biol. 2013; 102:97-126.
23. Wu J, Zheng ZX, Wang H, Mei XX, Ding XB, Li XY. Primordial Germ Cells and Germ Line Stem Cells. Stem Cells: Basics and Clinical Translation. 2015; 3-28.

Patents
1. Liu CB, Wang H, Zou LL, Ma JL, Yang YG. “Cell penetrating peptide hPP8 and its application.” China Patent No. 3.5, August 14, 2018.
2. Liu CB, Wang H, Zou LL, Ma JL, Yang YG. “Cell penetrating peptide hPP5 and its application.” China Patent No. 0.9, December 14, 2018.
主持或参与科研项目
项目主持：
1. 国家自然科学基金青年项目、**、小鼠生殖干细胞向功能性甲状腺滤泡细胞转分化及其机制研究、2016/01-2018/12、18万元、在研、主持。
项目参与：
1. 国家自然科学基金面上项目、**、含穿膜肽重组转录因子FOXN1-TAT对衰老小鼠胸腺重建的作用及其细胞和分子机制研究、2017/01-2020/12、57万元、在研、参加。
2. 国家自然科学基金面上项目、**、miR-23b/27b/24-1基因簇靶向活化型HSC协同沉默Gremlin1和LOX逆转HF进程、2017/01-2020/12、58万元、在研、参加。
3. 国家自然科学基金面上项目、**、分枝杆菌细胞壁脂质PDIM调控SUMO修饰介导肉芽肿形成的分子机制、2016/01-2017/12、30万元、在研、参加。
4. 国家重大科学研究计划项目、2013CB967400、精原细胞向生殖干细胞和生殖细胞转化的机制研究、2013/01-2017/08、2400万元、在研、参加。
5. 国家自然科学基金青年项目、**、小鼠雌性生殖干细胞体外分化及其分子机制、2013/01-2015/12、23万元、在研、参加。
6. 国家自然科学基金面上项目、**、驱动蛋白Oocyte-G1对生殖细胞发育的作用及其机制、2014/01-2017/12、70万元、在研、参加。
7. 国家自然科学基金青年项目、**、CRT促进DC疫苗抗肿瘤特异性免疫应答研究、2013/01-2015/12、25万元、在研、参加。
8. 肿瘤微环境与免疫治疗湖北省重点实验室开放基金、2015KZL09、喹唑啉类蛋白酪氨酸激酶抑制剂的设计、合成与活性研究、2016/01-2017/12、2万元、在研、参加。
学术兼职
Editorial Board Appointments
2015-present Editor, Stem Cell Epigenetics
2016-present Editor, Austin Journal of Reproductive Medicine & Infertility
2016-present Editor, Austin Biology
2016-present Editor, SM Journal of Stem Cell Research
2017-present Lead Guest Editor, Stem Cells International (IF=3.989)
2017-present Lead Guest Editor, Current Medical Chemistry (IF=3.469)
2018-present Editor, World J Stem Cells (IF=4.376)

Journal peer review activities
2016.04-present Reviewer, Acta Biochimica et Biophysica Sinica (IF=2.224)
2016.10-present Reviewer, Biomedicine & Pharmacotherapy (IF=3.457)
2016.10-present Reviewer, Oncotarget (IF=5.168)
2017.03-present Reviewer, Medical Science Monitor (IF=1.894)
2018.03-present Reviewer, World J Stem Cells (IF=4.376)
2018.10-present Reviewer, Expert Opinion on Drug Delivery (IF=5.553)
2018.10-present Reviewer, Journal of Neuro-Oncology (IF=3.060)
2019.01-present Reviewer, Cell Proliferation (IF=4.936)